Keywords: novartis, kissei, develop, new, class, glaucoma, treatment

Novartis and Kissei develop new class of glaucoma treatment

Article | 18 December 2001

Print This

Novartis Ophthalmics, the eye health unit of Novartis, and Japan'sKissei Pharmaceutical have entered a license option agreement for a novel ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in